Quick Answer
Eton Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 27.05 million shares for the year ending 2025.
- Eton Pharmaceuticals, Inc. showed an increase of +1.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Eton Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: 6.22 million shares | Q1 2019: 17.63 million shares | Q2 2019: 17.76 million shares | Q3 2019: 17.81 million shares | Q1 2020: 20.76 million shares | Q2 2020: 20.96 million shares | Q3 2020: 20.99 million shares | Q1 2021: 24.48 million shares | Q2 2021: 24.60 million shares | Q3 2021: 24.61 million shares | Q1 2022: 24.63 million shares | Q2 2022: 25.27 million shares | Q3 2022: 25.30 million shares | Q4 2022: 25.35 million shares | Q1 2023: 25.50 million shares | Q2 2023: 25.56 million shares | Q3 2023: 25.66 million shares | Q1 2024: 25.69 million shares | Q2 2024: 25.75 million shares | Q3 2024: 25.84 million shares | Q1 2025: 26.82 million shares | Q2 2025: 26.82 million shares | Q3 2025: 26.82 million shares.
- Over the full 9 years of available data (2017 to 2025), Eton Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has grown by 350.8%.
- Historical annual values: Fiscal year 2025: 27.05 million shares | Fiscal year 2024: 26.71 million shares | Fiscal year 2023: 25.69 million shares | Fiscal year 2022: 25.35 million shares | Fiscal year 2021: 24.63 million shares | Fiscal year 2020: 24.31 million shares | Fiscal year 2019: 17.88 million shares | Fiscal year 2018: 17.61 million shares | Fiscal year 2017: 6.00 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: